Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression

BACKGROUND: Electroconvulsive therapy (ECT) has long been used for treating individuals with treatment-resistant depression (TRD). Esketamine has recently emerged as a new treatment for TRD due to its rapid antidepressant effects. To further inform the decision regarding choice of treatment, this pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Degerlund Maldi, Kinza, Asellus, Peter, Myléus, Anna, Norström, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650406/
https://www.ncbi.nlm.nih.gov/pubmed/34876085
http://dx.doi.org/10.1186/s12888-021-03601-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650406/
https://www.ncbi.nlm.nih.gov/pubmed/34876085
http://dx.doi.org/10.1186/s12888-021-03601-8

Ejemplares similares